Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.

Dr. Barry Dworkin

Medical Mythbusting Commentary for February 4, 2021

[display_podcast]

Source:
U.K. says new study vindicates delaying 2nd AstraZeneca shot

Reference:
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Related posts:

  1. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  2. Retrospective study finds that the flu vaccine has benefits against severe effects of COVID-19. How it does this remains unknown but if true, it will be fascinating and enlightening to figure out how our immune response works in this setting.
  3. 2014-15 flu shot was ineffective because the virus mutated after vaccine went into production
  4. A post hoc ergo propter hoc moment: Quebec City care home outbreak after COVID-19 vaccination was not because vaccine did not work; it did not have enough time to do so. It also did not cause the outbreak; you cannot get Covid-19 from the vaccine.